本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Krystal Biotech Inc.

336.68
-3.3500-0.99%
成交量:22.58萬
成交額:7,581.41萬
市值:99.65億
市盈率:42.27
高:340.09
開:339.01
低:331.79
收:340.03
52周最高:382.54
52周最低:151.88
股本:2,959.88萬
流通股本:2,353.93萬
量比:0.98
換手率:0.96%
股息:- -
股息率:- -
每股收益(TTM):7.97
每股收益(LYR):6.84
淨資產收益率:20.12%
總資產收益率:9.37%
市淨率:7.33
市盈率(LYR):49.22

資料載入中...

2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/21

重要事件披露

Form 8-K - Current report
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/04

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities